SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-05-003937
Filing Date
2005-07-15
Accepted
2005-07-15 12:08:57
Documents
1
Effectiveness Date
2005-07-15

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. DEFA14A b55869tkdefa14a.htm DEFA14A 16779
  Complete submission text file 0000950135-05-003937.txt   18080
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21481 | Film No.: 05956401
SIC: 2836 Biological Products, (No Diagnostic Substances)